Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.55 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
| ▸ | GABRE | P78334 | 2/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.41 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.41 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.41 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081400 | 1.00 | ZDHHC7 (0.55) | ZDHHC7GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL30081398 | 1.00 | ZDHHC7 (0.55) | ZDHHC7GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL28812350 | 0.84 | ZDHHC7 (0.68) | ZDHHC7TSHR | |
| SCHEMBL5965786 | 0.84 | ZDHHC7 (0.65) | ZDHHC7TSHRCA1CA2SMN1; SMN2 | |
| SCHEMBL1415237 | 0.84 | ZDHHC7 (0.65) | ZDHHC7TSHRCA1CA2SMN1; SMN2 | |
| SCHEMBL9620422 | 0.83 | ZDHHC7 (0.43) | ZDHHC7GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL12358675 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1CA1CA2 | |
| SCHEMBL29589922 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1CA1CA2 | |
| SCHEMBL26139447 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRCA1CA2SMN1; SMN2 | |
| SCHEMBL868172 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114206300-A | Preventing and reducing keratinization disorder and related cosmetic | 默克专利股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| EP-3770160-A1 | GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS | Bracco Imaging SPA (IT) | 2021-01-27 | — | — | EP | disclosed |
| EP-3687994-B1 | GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS | BRACCO IMAGING SPA (IT) | 2020-11-04 | — | — | EP | disclosed |
| WO-2020030618-A1 | GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS | BRACCO IMAGING SPA (IT) | 2020-02-13 | — | — | WO | disclosed |
| US-20070098643-A1 | Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates | GUERBET (FR) | 2007-05-03 | — | — | US | disclosed |
| US-20060239926-A1 | Specific high-relaxivity compounds | GUERBET (FR) | 2006-10-26 | — | — | US | disclosed |
| EP-1635877-A2 | SPECIFIC HIGH-RELAXIVITY CONJUGATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING | GUERBET (FR) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004112839-A2 | SPECIFIC HIGH-RELAXIVITY CONJUGATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING | GUERBET (FR) | 2004-12-29 | — | — | WO | disclosed |
| US-6187285-B1 | IN PARTICULAR MAGNETIC RESONANCE IMAGING (MRI) FOR MAGNETIC CATIONS. | GUERBET (FR) | 2001-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070098643-A1 | Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates | MGAT2, MGAT1, MGAT3 | ZDHHC7 1024/4885GABRP 1933/4885GABRD 3136/4885 |
| US-20060239926-A1 | Specific high-relaxivity compounds | TNNC1, TNNT2, TNNI3 | ZDHHC7 3937/4885GABRP 4375/4885GABRD 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.